They were all, (maybe some)taking their own meds along with Xanamem. Would be nice if we could see all the data.
Explains the placebo abnormalities. Which also means, Xanamem did not do much.
[INTERVIEW] Actinogen Medical reveals XanaCIDD phase 2a trials, page-30
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
2.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $66.72M | |||
| Open | High | Low | Value | Volume |
| 2.2¢ | 2.2¢ | 2.1¢ | $34.32K | 1.606M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 3166166 | 2.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.2¢ | 867640 | 4 |
View Market Depth
| Last trade - 16.10pm 25/06/2025 (20 minute delay) ? |
| ACW (ASX) Chart |